4.7 Article

Vps33b regulates Vwf-positive vesicular trafficking in megakaryocytes

期刊

JOURNAL OF PATHOLOGY
卷 240, 期 1, 页码 108-119

出版社

WILEY
DOI: 10.1002/path.4762

关键词

megakaryocyte; platelet; -granules; VPS33B complex; vesicle trafficking

向作者/读者索取更多资源

Mutations of vacuolar protein sorting-associated protein 33b (VPS33B) cause arthrogryposis, renal dysfunction, and cholestasis syndrome, and a lack of platelet -granules in the affected patients. Conditional Vps33b knockout mice were developed to investigate the function(s) of Vps33b in platelet -granule formation. We found that early embryonic deletion of Vps33b was lethal. PF4-Cre-driven megakaryocyte-targeted Vps33b gene deletion greatly diminished Vps33b expression in platelets, but had no effect on platelet -granule formation and protein content. Tamoxifen-induced, haematopoietic stem cell (HSC)-specific Vps33b deletion completely depleted Vps33b in platelets, caused the absence of -granules, and increased the number of vacuoles in platelets and megakaryocytes. VPS33B association with VIPAS39, -tubulin, and SEC22B was identified by co-immunoprecipitation, mass spectra, and immunoblotting in human embryonic kidney 293T (HEK293T) cells. Also, pull-down experiments revealed that VIPAS39 bound to intact VPS33B; in contrast, -tubulin and SEC22B separately interacted with the sec1-like domains of VPS33B. Vps33b deficiency in megakaryocytes disturbs the redistribution of Vipas39 and Sec22b to proplatelets, and interrupted the co-localization of Sec22b with Vwf-positive vesicles. The data presented in this study suggest that Vps33b is involved in -granule formation possibly by facilitating the Vwf-positive vesicular trafficking to -granule-related vacuoles in megakaryocytes. Copyright (c) 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Hematology

2-Bromopalmitate targets retinoic acid receptor alpha and overcomes all-trans retinoic acid resistance of acute promyelocytic leukemia

Ying Lu, Jin-Song Yan, Li Xia, Kang Qin, Qian-Qian Yin, Hong-Tao Xu, Meng-Qing Gao, Xiao-Ning Qu, Yu-Ting Sun, Guo-Qiang Chen

HAEMATOLOGICA (2019)

Article Cell Biology

Metabolic Imaging Reveals a Unique Preference of Symmetric Cell Division and Homing of Leukemia-Initiating Cells in an Endosteal Niche

Xiaoxin Hao, Hao Gu, Chiqi Chen, Dan Huang, Yuzheng Zhao, Li Xie, Yejun Zou, Hui Sophie Shu, Yaping Zhang, Xiaoxiao He, Xiaoyun Lai, Xiaocui Zhang, Bo O. Zhou, Cheng Cheng Zhang, Guo-Qiang Chen, Zhuo Yu, Yi Yang, Junke Zheng

CELL METABOLISM (2019)

Article Oncology

FAM122A supports the growth of hepatocellular carcinoma cells and its deletion enhances Doxorubicin-induced cytotoxicity

Yong Zhou, Wen-Yang Shi, Wei He, Zhao-Wen Yan, Man-Hua Liu, Jing Chen, Yun-Sheng Yang, Yin-Qi Wang, Guo-Qiang Chen, Ying Huang

EXPERIMENTAL CELL RESEARCH (2020)

Article Biochemistry & Molecular Biology

Unraveling allosteric landscapes of allosterome with ASD

Xinyi Liu, Shaoyong Lu, Kun Song, Qiancheng Shen, Duan Ni, Qian Li, Xinheng He, Hao Zhang, Qi Wang, Yingyi Chen, Xinyi Li, Jing Wu, Chunquan Sheng, Guoqiang Chen, Yaqin Liu, Xuefeng Lu, Jian Zhang

NUCLEIC ACIDS RESEARCH (2020)

Article Hematology

MDH1-mediated malate-aspartate NADH shuttle maintains the activity levels of fetal liver hematopoietic stem cells

Hao Gu, Chiqi Chen, Xiaoxin Hao, Ni Su, Dan Huang, Yejun Zou, Shu-Hai Lin, Xianjun Chen, Denghao Zheng, Ligen Liu, Zhuo Yu, Li Xie, Yaping Zhang, Xiaoxiao He, Xiaoyun Lai, Xiaocui Zhang, Guo-Qiang Chen, Yuzheng Zhao, Yi Yang, Joseph Loscalzo, Junke Zheng

Article Multidisciplinary Sciences

FBXO22 degrades nuclear PTEN to promote tumorigenesis

Meng-Kai Ge, Na Zhang, Li Xia, Cheng Zhang, Shuang-Shu Dong, Zhan-Ming Li, Yan Ji, Min-Hua Zheng, Jing Sun, Guo-Qiang Chen, Shao-Ming Shen

NATURE COMMUNICATIONS (2020)

Article Cell Biology

P53 suppresses SENP3 phosphorylation to mediate G2 checkpoint

Yang Wang, Jing Tian, Chao Huang, Jiao Ma, Gaolei Hu, Yalan Chen, Tianshi Wang, Rong Cai, Yong Zuo, Hongsheng Tan, Qiuju Fan, Baijun Dong, Wei Xue, Jing Yi, Guoqiang Chen, Jun Tu, Jinke Cheng

CELL DISCOVERY (2020)

Article Cell & Tissue Engineering

FAM122A Inhibits Erythroid Differentiation through GATAI

Jing Chen, Qiong Zhou, Man-Hua Liu, Yun-Sheng Yang, Yin-Qi Wang, Ying Huang, Guo-Qiang Chen

STEM CELL REPORTS (2020)

Letter Oncology

FAM122A is required for hematopoietic stem cell function

Man-Hua Liu, Xiao-Cui Zhang, Jing Chen, Yun-Sheng Yang, Yin-Qi Wang, Jun-Ke Zheng, Guo-Qiang Chen, Ying Huang

LEUKEMIA (2021)

Article Multidisciplinary Sciences

Oxidative phosphorylation enhances the leukemogenic capacity and resistance to chemotherapy of B cell acute lymphoblastic leukemia

Chiqi Chen, Xiaoxin Hao, Xiaoyun Lai, Ligen Liu, Jun Zhu, Hongfang Shao, Dan Huang, Hao Gu, Tinghua Zhang, Zhuo Yu, Li Xie, Xiaocui Zhang, Yi Yang, Jun Xu, Yuzheng Zhao, Zhigang Lu, Junke Zheng

Summary: A recent study has shown that B-ALL cells with low SoNar ratio preferentially use oxidative phosphorylation and are more resistant to treatment, suggesting a potential connection between metabolism and B-ALL cell fates.

SCIENCE ADVANCES (2021)

Article Biochemistry & Molecular Biology

Epithelial cells-enriched lncRNA SNHG8 regulates chromatin condensation by binding to Histone H1s

Ping He, Cheng Zhang, Yan Ji, Meng-Kai Ge, Yun Yu, Na Zhang, Shuo Yang, Jian-Xiu Yu, Shao-Ming Shen, Guo-Qiang Chen

Summary: SNHG8, a chromatin-localized lncRNA, interacted and phase separated with histone H1 variants. It showed stronger binding ability to H1 proteins than linker DNA, leading to increased chromatin condensation and epithelial cell differentiation.

CELL DEATH AND DIFFERENTIATION (2022)

Article Biochemistry & Molecular Biology

MUC1 triggers lineage plasticity of Her2 positive mammary tumors

Zhi Pang, Xinran Dong, Huayun Deng, Chengzhi Wang, Xiaodong Liao, Chunhua Liao, Yahui Liao, Weidong Tian, Jinke Cheng, Guoqiang Chen, Haiying Yi, Lei Huang

Summary: Aberrant overexpression of MUC1 and HER2 is associated with breast cancer, and their concomitant expression leads to worse clinical outcome. In a mouse model, coexpression of Her2 and MUC1-CD promotes mammary tumor development and induces changes in tumor lineage plasticity and downregulation of tricarboxylic acid cycle genes. Furthermore, MUC1 enhances the Her2 signaling pathway by inducing Her2/Egfr dimerization.

ONCOGENE (2022)

Article Multidisciplinary Sciences

The phosphatase PTEN links platelets with immune regulatory functions of mouse T follicular helper cells

Xue Chen, Yanyan Xu, Qidi Chen, Heng Zhang, Yu Zeng, Yan Geng, Lei Shen, Fubin Li, Lei Chen, Guo-Qiang Chen, Chuanxin Huang, Junling Liu

Summary: PTEN-deficient platelets promote autoimmunity in mouse models through excessive activation of T-FH cells and systemic autoimmune pathology.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

PI3Kβ controls immune evasion in PTEN-deficient breast tumours

Johann S. Bergholz, Qiwei Wang, Qi Wang, Michelle Ramseier, Sanjay Prakadan, Weihua Wang, Rong Fang, Sheheryar Kabraji, Qian Zhou, G. Kenneth Gray, Kayley Abell-Hart, Shaozhen Xie, Xiaocan Guo, Hao Gu, Thanh Von, Tao Jiang, Shuang Tang, Gordon J. Freeman, Hye-Jung Kim, Alex K. Shalek, Thomas M. Roberts, Jean J. Zhao

Summary: In this study, it was found that genetic inactivation of PI3K beta can induce anti-tumor immune responses and inhibit the growth of PTEN-deficient breast cancer. This effect is associated with reduced STAT3 signaling and increased expression of immune stimulatory molecules. Pharmacological inhibition of PI3K beta also elicits anti-tumor immunity and synergizes with immunotherapy to inhibit tumor growth. Therefore, the combination of PI3K beta inhibitors and immunotherapy may be a rational treatment approach for PTEN-deficient breast cancer.

NATURE (2023)

Article Oncology

FAM122A maintains DNA stability possibly through the regulation of topoisomerase IIα expression

Yin-Qi Wang, Yun-Sheng Yang, Jing Chen, Man-Hua Liu, Guo-Qiang Chen, Ying Huang

EXPERIMENTAL CELL RESEARCH (2020)

暂无数据